Anhui Zhifei Longcom: RBD-Dimer

Vaccine Type: Protein Subunit

Vaccine Trial & Approval Tracker

This vaccine has reached Phase 3 trials.

About Trial Phases

Phase 1: 3 Trials

Phase 2: 1 Trial

Phase 3: 1 Trial

Approvals: 0 Approvals

This vaccine is not yet approved.

Registered Trials